In individuals with obesity, lower IGF-1 serum levels and a blunted response to growth hormone-stimulating dynamic tests are associated with greater metabolic impairment [18,19,20,21,22,23,24,25]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.